Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus

Hepato-Gastroenterology

Volumn 43, Issue 10, 1996, Pages 1079-1083

  Tamori, Akihiro ^a   Kuroki, Tetsuo ^a   Nishiguchi, Shuhei ^a   Morimoto, Hideki ^a   Morimoto, Misayo ^a   Hirohashi, Kazuhiro ^b   Kinoshita, A Hiroaki ^a   Kobayashi, Kenzo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

fetoprotein; Caudate lobe; Hepatocellular carcinoma; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; INTERFERON; ALPHA2A INTERFERON; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; ENZYME ACTIVITY; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; FOLLOW UP; LIVER; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; TIME; VIROLOGY;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030179446     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bruix J, Barrera JM, Calvet X, G, Costa J, Sanchez-Tapias JM, Venture M, All M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii: 1004-1006.
2. Colombo M, Kou G, Choo GL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Haughton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii: 1006-1008.
3. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M, Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
4. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo Q-L, Houghton M, Oda T. A high prevalance of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-433.
5. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 1986; 315: 1575-1578.
6. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-a therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299.
7. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomised trial of effects of interferon-a on the incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-1055.
8. Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E. Alpha interferon treatment prevents hepatocellular carcinoma in HCV related liver cirrhosis (abstract). Gastroenterology 1995; 108: A1120.
9. Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T, Yamamoto S. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14: 985-989.
10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-679.
11. Taketa K, Hirai H. Lectin affinity electrophoresis of a-fetoprotein in cancer diagnosis. Electrophoresis 1989; 10: 562-567.
12. Taketa K, Sekiya C., Namiki M, Akamatsu K, Ohta Y, Endo Y, Kosaka K. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990; 99: 508-518.
13. Takayasu K, Muramatsu Y, Shima Y, Goto H, Moriyama N, Yamada T, Makuuchi M, Kaneko A, Itabashi M, Shimamura Y. Clinical and radiologic features of hepatocellular carcinoma originating in the caudate lobe. Cancer 1986; 58: 1557-1562.
14. Shimada M, Matsumata T, Maedo T, Yanaga K, Taketomi A, Sugimachi K. Characteristics of hepatocellular carcinoma originating in the caudate lobe. Hepatology 1994; 19: 911-915.
15. Nomura F, Ohnishi K, Tunabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients. Cancer 1989; 64: 1700-1707.
16. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu A, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336: 1150-1153.
17. Srhwartz M. A biomathematical approach to clinical tumor growth. Cancer 1961; 14: 1272-1294.
18. Sheu J-C, Sung J-L, Chen D-S, Yang P-M, Lai M-Y, Lee C-S, Hsu H-C, Chuang C-N, Yang P-C, Wang T-H, Lin J-T, Lee C-Z. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-266.